Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion type Assertion NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_head.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion wasGeneratedBy ECO_0000203 NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_provenance.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion wasDerivedFrom befree-20140225 NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_provenance.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion SIO_000772 23086750 NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_provenance.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion evidence source_evidence_literature NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_provenance.
- NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_assertion description "[We have assessed the impact of these mutations in a cohort of 494 patients treated within the randomized phase 3 United Kingdom Leukaemia Research Fund Chronic Lymphocytic Leukemia 4 (UK LRF CCL4) trial that compared chlorambucil and fludarabine with and without cyclophosphamide in previously untreated patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485225.RAc15SowgrA-uF0ODgavBbFoDfu9m6kpkL8f5o_qfxWEA130_provenance.